Page URL: https://www.bionews.org.uk/page_93852

Glasgow centre buyout births UK's largest IVF provider

5 November 2012
Appeared in BioNews 680

The Academic Research Partnership (ARP) has bought a majority stake in the Glasgow Centre for Reproductive Medicine (GCRM), reportedly creating the UK's largest provider of NHS and private IVF services.

According to a statement, the move is ARP's third 'partnership' in the UK and follows mergers with the Oxford Fertility Unit and IVF Hammersmith.

GCRM managing director Paul Mitchell told The Herald newspaper that the company had grown significantly since it was founded and 'in terms of business development, [the buyout] was the next logical step'.

Established in 2006, GCRM is based in Glasgow with a satellite clinic in Edinburgh. Three of the four GCRM shareholders will stay with the company to play an 'active role in its growth', according to a statement. All 45 GCRM staff will be maintained in the deal.

GCRM was advised by Scottish law firm Harper Macleod and accountancy advisors PRK. PRK's press statement announcing the merger, said the expansion of the partnership would allow patients to 'benefit from the sharing of best practice and scientific resources by teams across the UK who are at the pinnacle of the assisted reproduction sector'.

Speaking with The Herald, Mitchell confirmed that staff training and development would take on 'a whole different structure'. He added that he hoped that the buyout would also lead to further investment in an enhanced clinical research capability.

'Research has always been a big part of what we do', he said. 'But with six clinics the data we can collect and generate and the clinical trials we can conduct should help push everything forward and accelerate future developments in infertility treatment'.

The UK fertility market is estimated to be worth around £550 million a year and 75 percent of the UK's annual 50,000 IVF procedures are performed privately. 'It is expected', PRK's statement concludes, 'that growth will increase in the fertility sector'.

SOURCES & REFERENCES
Fertility group ARP in Glasgow centre merger
BBC News |  26 October 2012
GCRM merge with academic research partnership to create UK fertility leader
PKF (press release) |  26 October 2012
Home Page
Glasgow Centre for Reproductive Medicine |  13 December 2019
Infertility centre acquired by ARP in takeover deal
Herald Scotland |  26 October 2012
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
17 June 2013 - by Jessica Ware 
The first IVF business to be listed on the stock market enjoyed a buoyant first day of trading on the Australian exchange. Shares in Virtus Health closed 8.5 percent above their starting price, which was already set at the top end of an indicative range...
20 May 2013 - by Ruth Retassie 
The Scottish government has approved criteria which include new restrictions on access to state-funded IVF but which also aim to end the 'postcode lottery' faced by many couples with fertility problems...
21 May 2012 - by Ruth Retassie 
A London-based IVF clinic has received an investment from a private equity firm to open more fertility clinics in the UK and abroad....
23 April 2012 - by Dr Marianne Kennedy 
Women may soon be given the option of banking their ovarian tissue if a new clinic to offer the procedure opens in the UK. The technique allows women to freeze ovarian tissue containing eggs to use at a later date and could assist cancer patients and other women who hope to have children later in life....
4 April 2011 - by Kyrillos Georgiadis 
Britain's first 'gay-only' fertility centre has opened in Birmingham offering to help match potential parents with sperm or egg donors and surrogates....
16 September 2002 - by BioNews 
The first private fertility centre in Europe that exclusively caters for lesbian couples and single women opened today in London. The Harley Street centre does not yet have a licence to carry out treatments or store sperm, but its application is being considered by the UK's Human Fertilisation and Embryology...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.